CDKN1A and ovarian carcinoma: LncRNA FAL1 was amplified in more than 30% of ovarian cancers, which could promote cell proliferation by recruiting the chromatin repressor protein BMI‐1 and inhibiting the expression of CDKN1A (Hu et al., 2014).